Health

Fixing our broken health care system has been my top priority for most of my life. My goal is to ensure that every person has access to affordable, quality and accessible health care. It is a national shame that our nation spends more than any other country in the world but fails to guarantee access to health care. 50 million Americans are completely uninsured, millions more are poorly insured. High medical costs are a factor in a majority of personal bankruptcies, and businesses, small and large, are struggling to pay for health care for their workers.  

Lack of access to health care has resulted in the United States trailing the world in health outcomes.  In 2017, the United States ranked 170th in the infant mortality rate, 138th in the maternal mortality rate, and 43rd in life expectancy.  International comparisons by organizations such as the World Health Organization, OECD, and the Commonwealth Fund consistently show the U.S. rates poorly in meeting quality health measures despite spending far more than any other than country.

As a previous member of the House Energy and Commerce Committee's Subcommittee on Health, I am committed to building a health care system that works for everyone. We have made major strides in recent years, and I am especially proud of the passage of the historic Patient Protection and Affordable Care Act, known as Obamacare. It continues to benefit millions of Americans, and it lays a strong foundation to make even more improvements.

We have more to do to achieve breakthroughs in medical research and to eliminate disparities in access to care. We must expand the health care workforce. We must ensure that everyone has affordable access to the health care they need, including prescription drugs, mental health services and the full range of reproductive health services.

I believe we can create the best health care system in the world and that Obamacare was an excellent start.

More on Health

March 6, 2020 Press Release

Washington, D.C. – Today, Representative Jan Schakowsky (D-IL), a Senior Chief Deputy Whip and Chairwoman of the House Energy and Commerce Subcommittee on Consumer Protection and Commerce, U.S.

March 6, 2020 Press Release

WASHINGTON, DC – This week, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chair of the Energy and Commerce Consumer Protection and Commerce Subcommittee, was joined by Congressman Lloyd Doggett, Congresswoman Rosa DeLauro, Senator Chris Van Hollen, and several advocates from the Lower Drug Prices Now coalition to call on the White House and the Department of Health and Human Services (HHS) to protect public health and take steps to ensure that any 2019 novel coronavirus (COVID-19) vaccine or treatment developed with the help of taxpayer-funded research is affordable and acces

March 6, 2020 Video

Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chair of the Energy and Commerce Consumer Protection and Commerce Subcommittee, was joined by Congressman Lloyd Doggett, Congresswoman Rosa DeLauro, Senator Chris Van Hollen, and several advocates to call on the White House and the Department of Health and Human Services (HHS) to protect public health and take steps to ensure that any 2019 novel coronavirus (COVID-19) vaccine or treatment developed with the help of taxpayer-funded research is affordable and accessible to all Americans.

March 5, 2020 Press Release

WASHINGTON, DC - Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chair of the Consumer Protection and Commerce Subcommittee of the House Energy and Commerce Committee, released a statement on Congress’ approval of a $8.3 billion emergency supplemental appropriations bill to fully address the 2019 novel coronavirus (COVID-19) and protect Americans from this public health crisis:

March 3, 2020 Press Release

WASHINGTON, DC - Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chair of the Energy and Commerce Consumer Protection and Commerce Subcommittee, sent a letter to Department of Health and Human Services (HHS) to reiterate her concerns about awarding exclusive licenses for the production of a potential 2019 novel coronavirus (COVID-19) vaccine or treatment and allowing drug manufactures to monopolize drugs that have been funded by millions of taxpayer dollars. 

Pages